Notice of Change to participation on PAR-18-512 "Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer?s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)"

Notice Number: NOT-OD-18-140

Key Dates
Release Date: February 20, 2018

Related Announcements
PAR-18-512

Issued by
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Purpose

The purpose of this Notice is to inform potential applicants that ORIP/OD is not participating in PAR-18-512, "Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)".  This is effective as of the Release Date of this Notice.

Currently reads:
Components of Participating Organizations

National Institute on Aging (NIA)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)


 
Revised to read:
Components of Participating Organizations

National Institute on Aging (NIA)


All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

All FOA inquiries should be directed to NIA contacts listed in the PAR-18-512.